Human papillomavirus (HPV) 16 E6 has been proved to increase the radiosensitivity and
lead to the EGFR overexpression in cervical cancer cells. In this study, to investigate the …

Human papillomaviruses (HPV) are a major cause of malignancy worldwide, contributing
to~ 5% of all human cancers including almost all cases of cervical cancer and a growing …

Background Persistent infection with high-risk Human papillomaviruses (HPV), such as hr-
HPV-16 and hr-HPV-18, lead to cervical cancer, the fourth most common cancer in the …

In most cases of cervical cancer, the high risk of the disease is caused by the human
papilloma virus (HPV). Surgery or radiation usually benefits patients with early cervical …

The primary causes of cervical cancer are human papillomavirus type 16 (HPV16) and/or
other high-risk (Hr−) HPV infections. Hr-HPVE5, E6, and E7 have been identified as …

Persistent infection with oncogenic human papillomavirus viruses (HPVs) is a casual factor
for cervical cancer and its precursors and the abnormal constitutive expression of viral …

Human papillomaviruses (HPVs) are small double‐stranded circular DNA viruses with 8 kb
genomes. So far, more than 150 HPVs have been identified, and 12 types of HPVs have …

Background Human papillomavirus (HPV) is a risk factor for the occurrence of cervical
cancer (CC). Here, we aimed to explore the role of HPV16 in CC and identify the underlying …

Purpose Nimotuzumab is a humanized monoclonal antibody that targets the epidermal
growth factor receptor (EGFR) to inhibit tumor growth. Nimotuzumab has demonstrated …

Cervical cancer (CC) remains one of the most common female malignancies, with higher
incidence and mortality rates. more than 99% of CCs are associated with persistent infection …